Tuberculosis awareness in patients receiving anti-TNF therapy: a survey study

Ezgi Erdem Türe; Derya Doğan; Yağmur Gizem Timurhan; Merve Özdoğan Algın; Serap Duru

Tuberculosis awareness in patients receiving anti-TNF therapy: a survey study

Abstract

Aims: Tumor necrosis factor (TNF) inhibitors are widely used in the treatment of inflammatory and autoimmune diseases; however, they increase the risk of latent tuberculosis (TB) infection reactivation and active tuberculosis. This study aimed to evaluate tuberculosis-related knowledge and awareness among patients receiving anti-TNF therapy. Methods: This single-center, cross-sectional survey study included adult patients receiving anti-TNF therapy who attended a pulmonology clinic between May and November 2023. An 18-item questionnaire was administered through face-to-face interviews. A composite TB awareness score (range: 0-6) was calculated based on six items, and participants were categorized as having low (0-2), moderate (3-4), or high (5-6) awareness. Associations between awareness levels and clinical characteristics were analyzed, and ordinal logistic regression was performed to identify independent predictors. Results: A total of 145 patients were included. The patients’ mean age was 45.29±12.89 years, and 59.3% were female. Although 87.6% of participants believed that pulmonology consultation was necessary for anti-TNF approval, only 40.7% correctly identified TB screening as the primary purpose of this evaluation, while 46.9% perceived it as only a required signature. Nearly half of the participants (45.5%) reported no knowledge of TB symptoms. Overall, 32.4% of patients had low awareness, 55.2% moderate awareness, and 12.4% high awareness. In univariate ordinal logistic regression analyses, high school education was associated with lower awareness compared to university education, while TB prophylaxis was associated with higher awareness. In multivariate ordinal logistic regression analyses, primary school education was associated with lower awareness compared to university education. Conclusion: TB awareness among patients receiving anti-TNF therapy remained limited, even with regular clinical follow-up. Many patients perceived pulmonology consultations as administrative procedures rather than infection surveillance measures. These findings suggest that structured and repeated patient-centered educational interventions may be necessary to enhance TB awareness and promote appropriate preventive behaviors in this high-risk population.

Keywords

References

World Health Organization. Global tuberculosis report 2023. Geneva, Switzerland: World Health Organization; 2023.
Thavarajah K, Wu P, Rhew EJ, Yeldandi AK, Kamp DW. Pulmonary complications of tumor necrosis factor-targeted therapy. Respir Med. 2009;103(5):661-669. doi:10.1016/j.rmed.2009.01.002
Republic of Turkey Ministry of Health. Tüberküloz tanı ve tedavi rehberi [Tuberculosis diagnosis and treatment guideline]. Republic of Turkey Ministry of Health; 2019.
Algood HM, Lin PL, Flynn JL. Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis. Clin Infect Dis. 2005;41 Suppl 3:S189-S193. doi:10.1086/ 429994
British Thoracic Society Standards of Care Committee. BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment. Thorax. 2005;60(10):800-805. doi:10.1136/thx.2005.046797
Baddley JW, Cantini F, Goletti D, et al. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) consensus document on the safety of targeted and biological therapies: an infectious diseases perspective (soluble immune effector molecules [i]: anti-tumor necrosis factor-α agents). Clin Microbiol Infect. 2018;24 Suppl 2:S10-S20. doi:10. 1016/j.cmi.2017.12.025
Kanbay, A., & Yakar, H. İ. Biyolojik tedaviler ve tüberküloza yaklaşım. Karadağ AS, editör. Türkiye Klinikleri, Dermatolojide Biyolojik Tedaviler. 2021:12-16.
Republic of Turkey Ministry of Health, Public Health Institution of Turkey. Anti-TNF kullanan hastalarda tüberküloz rehberi. Published online 2014. Accessed March 23, 2022.

Godfrey MS, Friedman LN. Tuberculosis and biologic therapies: anti-tumor necrosis factor-α and beyond. Clin Chest Med. 2019;40(4):721-739. doi:10.1016/j.ccm.2019.07.003
Cagatay T, Aydin M, Sunmez S, et al. Follow-up results of 702 patients receiving tumor necrosis factor-α antagonists and evaluation of risk of tuberculosis. Rheumatol Int. 2010;30(11):1459-1463. doi:10.1007/s00296- 009-1170-6
Elbek O, Uyar M, Aydin N, et al. Increased risk of tuberculosis in patients treated with antitumor necrosis factor alpha. Clin Rheumatol. 2009;28(4):421-426. doi:10.1007/s10067-008-1067-x
Kigozi NG, Heunis JC, Engelbrecht MC, Janse van Rensburg AP, van Rensburg HCJD. Tuberculosis knowledge, attitudes and practices of patients at primary health care facilities in a South African metropolitan: research towards improved health education. BMC Public Health. 2017;17(1):795. doi:10.1186/s12889-017-4825-3
Bisallah CI, Rampal L, Lye MS, et al. Effectiveness of health education intervention in improving knowledge, attitude, and practices regarding Tuberculosis among HIV patients in General Hospital Minna, Nigeria-a randomized control trial. PLoS One. 2018;13(2):e0192276. doi:10.1371/journal.pone.0192276
Chauhan A, Parmar M, Dash GC, et al. Health literacy and tuberculosis control: systematic review and meta-analysis. Bull World Health Organ. 2024;102(6):421-431. doi:10.2471/BLT.23.290396
Nisar MK, Rafiq A, Östör AJ. Biologic therapy for inflammatory arthritis and latent tuberculosis: real world experience from a high prevalence area in the United Kingdom. Clin Rheumatol. 2015;34(12):2141-2145. doi:10.1007/s10067-015-3099-3

Details

Primary Language

English

Subjects

Chest Diseases

Journal Section

Research Article

Authors

Ezgi Erdem Türe ^*
0000-0003-4285-3338
Türkiye

Derya Doğan This is me
0000-0003-1455-8681
Türkiye

Yağmur Gizem Timurhan This is me
0000-0002-7374-0363
Türkiye

Merve Özdoğan Algın This is me
0009-0001-4271-8091
Türkiye

Serap Duru
0000-0001-5030-5695
Türkiye

Publication Date

May 22, 2026

Submission Date

February 21, 2026

Acceptance Date

April 8, 2026

Published in Issue

Year 2026 Volume: 8 Number: 3

IZ

https://izlik.org/JA92KW55NL

Cite

RIS / Bibtex

APA

Erdem Türe, E., Doğan, D., Timurhan, Y. G., Özdoğan Algın, M., & Duru, S. (2026). Tuberculosis awareness in patients receiving anti-TNF therapy: a survey study. Anatolian Current Medical Journal, 8(3), 435-441. https://izlik.org/JA92KW55NL

AMA

1.Erdem Türe E, Doğan D, Timurhan YG, Özdoğan Algın M, Duru S. Tuberculosis awareness in patients receiving anti-TNF therapy: a survey study. Anatolian Curr Med J / ACMJ / acmj. 2026;8(3):435-441. https://izlik.org/JA92KW55NL

Chicago

Erdem Türe, Ezgi, Derya Doğan, Yağmur Gizem Timurhan, Merve Özdoğan Algın, and Serap Duru. 2026. “Tuberculosis Awareness in Patients Receiving Anti-TNF Therapy: A Survey Study”. Anatolian Current Medical Journal 8 (3): 435-41. https://izlik.org/JA92KW55NL.

EndNote

Erdem Türe E, Doğan D, Timurhan YG, Özdoğan Algın M, Duru S (May 1, 2026) Tuberculosis awareness in patients receiving anti-TNF therapy: a survey study. Anatolian Current Medical Journal 8 3 435–441.

IEEE

[1]E. Erdem Türe, D. Doğan, Y. G. Timurhan, M. Özdoğan Algın, and S. Duru, “Tuberculosis awareness in patients receiving anti-TNF therapy: a survey study”, Anatolian Curr Med J / ACMJ / acmj, vol. 8, no. 3, pp. 435–441, May 2026, [Online]. Available: https://izlik.org/JA92KW55NL

ISNAD

Erdem Türe, Ezgi - Doğan, Derya - Timurhan, Yağmur Gizem - Özdoğan Algın, Merve - Duru, Serap. “Tuberculosis Awareness in Patients Receiving Anti-TNF Therapy: A Survey Study”. Anatolian Current Medical Journal 8/3 (May 1, 2026): 435-441. https://izlik.org/JA92KW55NL.

JAMA

1.Erdem Türe E, Doğan D, Timurhan YG, Özdoğan Algın M, Duru S. Tuberculosis awareness in patients receiving anti-TNF therapy: a survey study. Anatolian Curr Med J / ACMJ / acmj. 2026;8:435–441.

MLA

Erdem Türe, Ezgi, et al. “Tuberculosis Awareness in Patients Receiving Anti-TNF Therapy: A Survey Study”. Anatolian Current Medical Journal, vol. 8, no. 3, May 2026, pp. 435-41, https://izlik.org/JA92KW55NL.

Vancouver

1.Ezgi Erdem Türe, Derya Doğan, Yağmur Gizem Timurhan, Merve Özdoğan Algın, Serap Duru. Tuberculosis awareness in patients receiving anti-TNF therapy: a survey study. Anatolian Curr Med J / ACMJ / acmj [Internet]. 2026 May 1;8(3):435-41. Available from: https://izlik.org/JA92KW55NL